Workshop on Growing Use of Cryoprecipitate Held at Saral Blood Centre

Udaipur:In routine medical practice, it is often observed that patients are transfused with whole plasma (FFP) even when only specific plasma components are required. This not only reduces therapeutic effectiveness but may also cause unnecessary complications. Addressing this issue, Saral Blood Centre, Udaipur, has installed an advanced Cryoprecipitate preparation system, making it the first blood centre in southern Rajasthan to provide component-specific plasma therapy.

To promote awareness and clinical implementation, a workshop on the “Growing Clinical Utility of Cryoprecipitate” was organised at the Saral Blood Centre auditorium in the presence of eminent physicians of the city. The workshop was conducted as a follow-up to the state-level conference on “Advances in Transfusion Medicine” organised by Saral Sanstha in September 2025, aiming to translate academic discussions into practical application and public awareness.

Welcoming the participants, CA (Dr) Shyam S. Singhi, Honorary Secretary of Saral Sanstha, informed that Saral Blood Centre has been serving the region for over 17 years and has the distinction of being the first blood centre in southern Rajasthan licensed to prepare all types of blood components, including Cryoprecipitate. He added that the centre has procured a state-of-the-art RemiMake Thawing Bath system specifically for Cryoprecipitate preparation.

Dr Singhi highlighted that despite best efforts, Cryoprecipitate remains underutilised in clinical practice, while Fresh Frozen Plasma (FFP) continues to be preferred. This often leads to transfusion of unnecessary proteins and coagulation factors, which may adversely affect patients. He expressed gratitude to Dr Narendra Mogra, Blood Bank In-charge, and his dedicated team for their continuous efforts in promoting component therapy and expressed hope that clinicians would increasingly adopt Cryoprecipitate-based treatment.

Delivering a detailed presentation, Dr Narendra Mogra explained that Cryoprecipitate contains a high concentration of fibrinogen, coagulation factors VIII and XIII, von Willebrand factor, and fibronectin, with relatively low protein content. The standard volume of Cryoprecipitate is approximately 15 ml, making it clinically efficient. He stated that Cryoprecipitate is especially useful in cases of massive bleeding, disseminated intravascular coagulation (DIC), surgical and accidental trauma, and renal failure.

Dr Mogra further pointed out that FFP transfusion involves a volume of nearly 180 ml, increasing the risk of circulatory overload, particularly in paediatric and elderly patients. In comparison, Cryoprecipitate is cost-effective, safer, and due to its low volume, does not require ABO compatibility, making it more convenient for emergency use.

Sanyam Singhi, Co-Secretary of Saral Sanstha, informed that senior clinicians including Dr B.S. Bamb, transfusion medicine expert Dr Sanjay Prakash, medical oncologist Dr Sachin Jain, gynaecologist Dr N.K. Joshi, Dr Kalpesh Chaudhary, and Dr Vinod Porwal shared their clinical experiences and strongly advocated increased use of Cryoprecipitate. They also appreciated Saral Blood Centre’s pioneering initiative.

On the occasion, Saral Sanstha reiterated its commitment to long-term service and institutional continuity. Senior medical officers Dr Suresh Dangi and Dr Pranshu Sharma, who had served the blood centre for several years, were given a respectful farewell due to unavoidable circumstances.

The programme concluded with a vote of thanks to all participants.